Enhancing diagnostics through flow cytometry: overcoming barriers in low resource settings

Despite advancements in the treatment of acute lymphoblastic leukemia (ALL), survival rates vary greatly based on factors such as cancer subtype and geographical location. The use of diagnostic tools like immunophenotyping and measurable residual disease (MRD) detection by flow cytometry (FC) are ke...

Descripció completa

Dades bibliogràfiques

Autors principals:	Jeanine Alfaro, Patricia Valverde, Paola Salguero, Xiomara Arevalo, Pamela Ortega, Luisa Sanchez, Federico Antillon-Klussmann, Randall T. Hayden, Alicia Rodriguez, Monika L. Metzger, John K. Choi, Victor M. Santana, Paul E. Mead, Priya Kumar
Format:	Artigo
Idioma:	Inglês
Publicat:	Frontiers Media S.A. 2025-09-01
Col·lecció:	Frontiers in Oncology
Matèries:	low- and middle-income countries flow cytometry minimal residual disease pediatric acute lymphoblastic leukemia
Accés en línia:	https://www.frontiersin.org/articles/10.3389/fonc.2025.1604295/full
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!